Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.

Journal of biomarkers Pub Date : 2015-01-01 Epub Date: 2015-03-30 DOI:10.1155/2015/981458
Kamila Schmidt, Ian Podmore
{"title":"Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.","authors":"Kamila Schmidt,&nbsp;Ian Podmore","doi":"10.1155/2015/981458","DOIUrl":null,"url":null,"abstract":"<p><p>An early diagnosis and appropriate treatment are crucial in reducing mortality among people suffering from cancer. There is a lack of characteristic early clinical symptoms in most forms of cancer, which highlights the importance of investigating new methods for its early detection. One of the most promising methods is the analysis of volatile organic compounds (VOCs). VOCs are a diverse group of carbon-based chemicals that are present in exhaled breath and biofluids and may be collected from the headspace of these matrices. Different patterns of VOCs have been correlated with various diseases, cancer among them. Studies have also shown that cancer cells in vitro produce or consume specific VOCs that can serve as potential biomarkers that differentiate them from noncancerous cells. This review identifies the current challenges in the investigation of VOCs as potential cancer biomarkers, by the critical evaluation of available matrices for the in vivo and in vitro approaches in this field and by comparison of the main extraction and detection techniques that have been applied to date in this area of study. It also summarises complementary in vivo, ex vivo, and in vitro studies conducted to date in order to try to identify volatile biomarkers of cancer. </p>","PeriodicalId":91105,"journal":{"name":"Journal of biomarkers","volume":"2015 ","pages":"981458"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/981458","citationCount":"134","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomarkers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2015/981458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/3/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 134

Abstract

An early diagnosis and appropriate treatment are crucial in reducing mortality among people suffering from cancer. There is a lack of characteristic early clinical symptoms in most forms of cancer, which highlights the importance of investigating new methods for its early detection. One of the most promising methods is the analysis of volatile organic compounds (VOCs). VOCs are a diverse group of carbon-based chemicals that are present in exhaled breath and biofluids and may be collected from the headspace of these matrices. Different patterns of VOCs have been correlated with various diseases, cancer among them. Studies have also shown that cancer cells in vitro produce or consume specific VOCs that can serve as potential biomarkers that differentiate them from noncancerous cells. This review identifies the current challenges in the investigation of VOCs as potential cancer biomarkers, by the critical evaluation of available matrices for the in vivo and in vitro approaches in this field and by comparison of the main extraction and detection techniques that have been applied to date in this area of study. It also summarises complementary in vivo, ex vivo, and in vitro studies conducted to date in order to try to identify volatile biomarkers of cancer.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
挥发性有机化合物分析作为癌症潜在生物标志物的当前挑战。
早期诊断和适当治疗对于降低癌症患者的死亡率至关重要。大多数形式的癌症缺乏特征性的早期临床症状,这突出了研究早期发现癌症的新方法的重要性。最有前途的方法之一是挥发性有机化合物(VOCs)的分析。挥发性有机化合物是一组不同的碳基化学物质,存在于呼出的气体和生物体液中,可以从这些基质的顶部空间收集。不同类型的挥发性有机化合物与各种疾病有关,其中包括癌症。研究还表明,癌细胞在体外产生或消耗特定的挥发性有机化合物,这些挥发性有机化合物可以作为潜在的生物标志物,将癌细胞与非癌细胞区分开来。本文通过对该领域的体内和体外方法的可用基质的批判性评估,以及迄今为止在该研究领域应用的主要提取和检测技术的比较,确定了VOCs作为潜在癌症生物标志物的研究中当前面临的挑战。它还总结了迄今为止进行的补充体内、体外和体外研究,以试图识别癌症的挥发性生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Corrigendum to “Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis” Body Mass Index, Haemoglobin, and Total Lymphocyte Count as a Surrogate for CD4 Count in Resource Limited Settings. The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin. Cystatin-C as a Marker for Renal Impairment in Preeclampsia. Association Study between Promoter Polymorphism of TPH1 and Progression of Idiopathic Scoliosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1